Prior to 1979, bone marrow transplants were only performed with histocompatible sibling donors. Once it was established that histocompatible, unrelated donors could donate marrow for transplantation, the recruitment of such donors needed to be standardized. Blood donor centers had already identified the histocompatibility locus antigen (HLA) typing for donors who could be recruited to donate bone marrow. Recruiting a large number of donors required systematic evaluation and testing according to defined standards which were published in 1988 by the National Mar row Donor Program (NMDP). Peripheral stem cell collection (PBS) has been added as a transplant source. It promises additional therapeutic modalities, such as gene splicing to address ...
Allogeneic hematopoietic cell transplantation involves consideration of both donor and recipient cha...
AbstractThe impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Engraftment of allogeneic hematopoietic stem cells has initially been achieved by selecting human le...
The chance of finding an unrelated bone marrow donor depends on the size of the donor registry, the ...
A letter report issued by the General Accounting Office with an abstract that begins "More than 30,0...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Peripheral blood (PB) and bone marrow (BM) from unrelated donors can serve as a graft source for hem...
Large registries of potential unrelated stem cell donors have been established in order to enable st...
AbstractIn the 20 years since the National Marrow Donor Program (NMDP) facilitated the first unrelat...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Allogeneic bone marrow transplantation (BMT) from HLA-identical sibling donors has been accepted as ...
AbstractThe National Marrow Donor Program (NMDP) has facilitated unrelated donor hematopoietic cell ...
Allogeneic hematopoietic cell transplantation involves consideration of both donor and recipient cha...
AbstractThe impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Hematopoietic stem cell transplantation (HSCT) is the therapy of choice in many hematological malign...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Engraftment of allogeneic hematopoietic stem cells has initially been achieved by selecting human le...
The chance of finding an unrelated bone marrow donor depends on the size of the donor registry, the ...
A letter report issued by the General Accounting Office with an abstract that begins "More than 30,0...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Peripheral blood (PB) and bone marrow (BM) from unrelated donors can serve as a graft source for hem...
Large registries of potential unrelated stem cell donors have been established in order to enable st...
AbstractIn the 20 years since the National Marrow Donor Program (NMDP) facilitated the first unrelat...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...
Allogeneic bone marrow transplantation (BMT) from HLA-identical sibling donors has been accepted as ...
AbstractThe National Marrow Donor Program (NMDP) has facilitated unrelated donor hematopoietic cell ...
Allogeneic hematopoietic cell transplantation involves consideration of both donor and recipient cha...
AbstractThe impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for...
Unrelated donor bone marrow transplant (UD-BMT) has become an attractive alternative source of hemat...